AmInvest Research Reports

Malaysian Pacific Industries - Weak 2HFY20 already factored in

AmInvest
Publish date: Thu, 21 May 2020, 06:32 PM
AmInvest
0 9,055
An official blog in I3investor to publish research reports provided by AmInvest research team.

All materials published here are prepared by AmInvest. For latest offers on AmInvest trading products and news, please refer to: https://www.aminvest.com/eng/Pages/home.aspx

Tel: +603 2036 1800 / +603 2032 2888
Fax: +603 2031 5210
Email: enquiries@aminvest.com

Office Hours
Monday to Thursday: 8:45am – 5:45pm
Friday: 8:45am – 5:00pm
(GMT +08:00 Malaysia)

Investment Highlights

  • We keep our BUY recommendation on Malaysian Pacific Industries (MPI) with unchanged forecasts and fair value of RM12.06/share, pegged to an FY21F PE of 15x.
  • MPI’s 3QFY20 core profit of RM21mil was in line with expectations, bringing 9MFY20 core profit to RM106mil. This is after stripping off net one-off losses amounting RM2mil mainly as forex losses and provision & write-off of inventories were partially offset by gross dividend income from short-term investments. The results accounted for 78% of our full-year estimates and 74% of consensus’ estimates.
  • YoY: 9MFY20 core profit fell 3% due to the exclusion of larger exceptional loss in 9MFY19 of RM11mil (vs. RM2mil loss in 9MFY20) amid larger forex losses and provision & write-off of inventories despite higher dividend income from investments. Otherwise, PBT rose by 0.1% in tandem with a 2% rise in overall revenue as sales in Asia rose 7%, offsetting 10% and 6% declines in the USA and Europe respectively. In 9MFY20, Asia, the USA, and Europe contributed 65%, 14% and 23% of total revenue respectively.
  • QoQ: 3QFY20 core profit plunged 56% as revenue dropped 9% due to sales across all regions being impacted by Covid-19 containment measures taken by MPI’s production facilities in Ipoh and Suzhou (China) e.g. travel restrictions, etc.
  • Outlook: Effective 29 April 2020, companies that have received the Ministry of International Trade and Industry’s approval to operate during the MCO were allowed to operate at 100% workforce capacity without restriction to working hours – which also include MPI. This bodes well for its Ipoh plant which contributes 70% of group revenue. Meanwhile, its Suzhou operations have returned to its preCovid-19 utilization rate of 104% after China eased its lockdown measures. However, the group shared that its order visibility has not been spared from uncertainties in demand relating to Covid-19 which is expected to affect its subsequent quarters. Since we have already factored in an overall weak 2H, we make no changes to earnings forecasts.
  • We continue to like MPI despite short-term headwinds relating to Covid-19, expecting recovery from FY21F onwards. MPI’s mid-to-long-term prospects are positive due to: (i) its portfolio rationalization strategy that focuses on highermargin specialized projects; (ii) its leading market position in the ultra-thin MLP and increased R&D in MEMS sensors riding on the IoT wave; (iii) its move towards producing silicon carbide power products with applications in EVs, and (iv) its strong net cash position of RM809mil as at 31 March 2020.

Source: AmInvest Research - 21 May 2020

Related Stocks
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment